Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Takeda Highlights Value Of Late-Stage Pipeline
Peak Potential Of $10bn-20bn
Dec 19 2024
•
By
Ian Haydock
Takeda lays out prospects for late-stage pipeline • Source: Takeda
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from R&D
More from Neurological